Capital Insight Partners, LLC Eli Lilly & CO Transaction History

Capital Insight Partners, LLC

$524 Million
Q2 2024

A detailed history of Capital Insight Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Capital Insight Partners, LLC holds 1,514 shares of LLY stock, worth $1.35 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

1,514

Previous 1,589 4.72%

Holding current value

$1.35 Million

Previous $1.24 Million 10.84%

% of portfolio

0.26%

Previous 0.23%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$724.87 - $909.04 $54,365 - $68,178	-75 Reduced 4.72%	1,514 $1.37 Million
Q1 2024 Apr 16, 2024	SELL	$592.2 - $792.28 $153,379 - $205,200	-259 Reduced 14.02%	1,589 $1.24 Million
Q4 2023 Jan 24, 2024	SELL	$525.19 - $619.13 $165,434 - $195,025	-315 Reduced 14.56%	1,848 $1.08 Million
Q3 2023 Oct 30, 2023	SELL	$434.7 - $599.3 $54,337 - $74,912	-125 Reduced 5.46%	2,163 $1.16 Million
Q2 2023 Jul 21, 2023	SELL	$350.74 - $468.98 $220,264 - $294,519	-628 Reduced 21.54%	2,288 $1.07 Million
Q1 2023 Apr 27, 2023	BUY	$310.63 - $364.82 $246,950 - $290,031	795 Added 37.48%	2,916 $1 Million
Q4 2022 Feb 07, 2023	SELL	$321.55 - $374.67 $45,017 - $52,453	-140 Reduced 6.19%	2,121 $775,000
Q3 2022 Oct 20, 2022	SELL	$296.48 - $337.87 $44,472 - $50,680	-150 Reduced 6.22%	2,261 $731,000
Q4 2021 Jan 20, 2022	SELL	$224.85 - $279.04 $42,721 - $53,017	-190 Reduced 7.3%	2,411 $666,000
Q3 2021 Oct 13, 2021	SELL	$221.6 - $272.71 $42,104 - $51,814	-190 Reduced 6.81%	2,601 $601,000
Q2 2021 Aug 02, 2021	SELL	$180.55 - $233.54 $56,331 - $72,864	-312 Reduced 10.05%	2,791 $641,000
Q1 2021 Apr 20, 2021	BUY	$164.32 - $212.72 $509,884 - $660,070	3,103 New	3,103 $580,000

Others Institutions Holding LLY

# of Institutions

3,869

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $847B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Insight Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Insight Partners, LLC with notifications on news.

Account

Capital Insight Partners, LLC Eli Lilly & CO Transaction History